Multidisciplinary · Defensible by Design

A specialist board
for every patient.
In minutes. With evidence. 24/7.

AiM gives your care team a multidisciplinary council of AI specialists — reviewing every case, challenging the consensus, and delivering recommendations you can trace, audit, and defend.

Multidisciplinary Simulation Demo
Watch the simulation
Multidisciplinary Simulation — council deliberation from intake through deliberation to the final report
Watch the simulation: from intake through deliberation to the final report — see how the council convenes specialists, surfaces dissent, and delivers a defensible recommendation.
Multiple specialists to every patient

A full tumor board review.
For every case.
Before treatment begins.

Assembling a tumor board takes weeks — most patients never get one. MedBoard convenes eleven specialist AI agents in minutes, a Red Team challenges the consensus, and the attending physician makes the final call.

MedBoard™ · Multi-Agent Deliberation
11 agents · running
MedBoard multi-disciplinary tumor board deliberation in progress
48M · GBM, IDH-wt MGMT-unmethylated · ICD-10 C71.1 · Live capture
Guideline Benchmark · Concordance Scoring

Every plan, scored
against the guidelines.
Gaps fixed before they reach the patient.

AiM checks every treatment plan against the latest clinical guidelines the moment it's drafted — a concordance score in seconds, every gap surfaced with a specific fix, from screening to advanced care.

Guideline Concordance · Live Scoring
Real-time
Case
64F · Breast Cancer, Stage IIIA · HR+/HER2− · ICD-10 C50.911
78/100
Guideline Concordance
3 gaps identified · 5 strengths confirmed
Imaging
100%
✓ Done
Staging
100%
✓ Done
Surgery
90%
Adjuvant Rx
65%
△ Partial
Genomic test
Missing
○ Gap
Surveillance
85%
! 3 suggestions to lift score
  • Order Oncotype DX · guideline-recommended for HR+/HER2−
  • Consider aromatase inhibitor over tamoxifen
  • Add BRCA1/2 testing — family history present
Drug Interactions · Agentic Orchestration

Drugs that harm.
Caught early.
Fixed safely.

AiM watches every patient's meds and labs together, detects when a medication is causing harm, recommends the safer fix — including stopping a drug — and keeps monitoring until it's resolved.

Iatrogenic Cascade · Maria A., 58 · T2D + HTN
Caught in 9 days
May 15
Lisinopril uptitrated 10 → 20 mgBP 150/92 · A1C 7.4 → 8.6%
May 22
HCTZ 25 mg addedhome BP still 148/90
May 30
Routine BMP — the regimen is the causeNa 129 ↓ · K 5.8 ↑ · eGFR 68 ↓
~Jun 1
Patient-started ibuprofen PRNOTC · off-chart · compounds K⁺ risk
Agentic Orchestrator · cascade detected, not a drug pairPatient Context · Interaction & Safety · Evidence · Therapy Ranking
Surface fix — reverse the harmhold HCTZ · swap ACE → ARB
stop NSAID · recheck BMP 5–7 d
Durable fix — lifestyle-first8-wk movement + diet trial
before a 3rd drug or GLP-1
Spawns Screen Profile — not an alertdrug_induced_electrolyte_review · monitors until resolved
FDARx · FDA eSTAR Regulatory Submission

Your FDA submission.
Built right the first time.
In months, not years.

FDARx assembles your 510(k), De Novo, or PMA on the FDA eSTAR template — predicate research, equivalence narratives, testing, risk, and cybersecurity — validated and first-pass ready.

FDARx · Submission Builder
Draft assembled
Project
Class II Cardiac Event Monitor · AI-enabled
510(k)
86%
Submission readiness
9 of 11 sections complete · 2 pending review
−8 mo
vs baseline
General info
✓ Done
Indications
✓ Done
Device desc.
✓ Done
Substantial
95%
Performance
72%
Risk analysis
90%
Software/Cyber
68%
Labeling
✓ Done
Next to first-pass ready

Complete cybersecurity bill of materials (SBOM) and finalize bench testing protocol. Estimated 9 working days to submission-ready.

Our Mission

Democratizing access to
collaborative clinical intelligence.

Historically, multidisciplinary deliberation has only been available to a small percentage of patients. AIM One Health helps extend coordinated clinical intelligence to every patient — not just those in major academic centers.

<5%
of patients ever sit before a full tumor board
~20
academic centers with full subspecialty depth
8B+
people who deserve the same standard of care
Connected Care Experiences

Care that connects, by design.

AIM One Health helps care teams work together more effectively — connecting patients, physicians, specialists, and operations through coordinated intelligence and collaborative care workflows.

Coordinated Intelligence

AI-assisted clinical intelligence grounded in evidence, physician oversight, and cross-specialty collaboration.

  • Cross-specialty reasoning, end to end
  • Citation-grounded recommendations
  • Always physician-supervised

Multidisciplinary Collaboration

Bring specialists, care teams, payers, and patients into a shared clinical conversation — where consensus forms in minutes instead of weeks.

  • Tumor boards in minutes, not weeks
  • Physicians, payers, patients aligned
  • Decisions made together, transparently

Operationally Connected Workflows

Connects with your existing EHR and care operations — so care transitions don't break, referrals close, and the data already in your system finally starts working together.

  • Works with Epic, Cerner, Athena & more
  • Care transitions stay intact
  • Referrals close, every time
Connected Care Communities

Clinical intelligence that grows with the community.

Each validated decision contributes to a continuously improving ecosystem of operational and clinical intelligence across participating care networks. The more institutions that join, the smarter every member becomes — and every patient benefits.

Cycles of learning — never stops
100%
Decisions validated & auditable
N+1
Every new member improves the whole
Hospital Clinic Network Specialty Research Payer Community AiM
Measurable Outcomes

What changes when you put AiM in your clinicians' hands.

Real outcomes from pilot deployments across primary care, cardiology, and inpatient medicine. The numbers that matter to a CMO, a CFO, and the clinicians who actually use it.

−5 hrs
Documentation time per clinician, weekly
≈ 230 hours/clinician/year returned to patient care
−25%
30-day readmission rate
≈ $15K Medicare cost avoided per readmission prevented
+40%
Faster specialist referrals
Referral revenue retained in-network instead of leaking out
Clinician retention vs. baseline
≈ $500K–$1M replacement cost avoided per clinician retained
12-18%
Revenue lift per encounter
≈ $30K added per 1,000 encounters from accurate coding
+22
HCAHPS provider rating points
Higher value-based purchasing reimbursement
6 wks
Typical pilot-to-production
Live this quarter, not next year — no EHR migration
90d
Typical payback period
Full investment recovered in one quarter, per 100 clinicians
Built for Every Specialty

Specialty-tuned simulation & intelligence.

AiM ships with scenario libraries, decision graphs, and reasoning pathways for the specialties that need them most — and your clinicians can add their own.

For the first time, I have a tool that lets me model the decision before I make it — and walks me through the evidence at the same time. My residents are learning faster, my patients are safer, and I'm home for dinner. That's three wins from one platform.
EW
Dr. Ellen Whitmore, MD
Chief Medical Officer · Urban Health Network
−23%
Readmissions, year one
94%
Clinician retention
$3.1M
Net annual ROI
2 days
HIPAA audit duration
Go Deeper

Resources for the curious clinician and the careful buyer.

The architecture, the philosophy, and the clinical evidence behind AiM — in formats built for serious readers.

See AiM in your environment.

Book a 30-minute walkthrough with the AIM One Health clinical informatics team. We'll show you how AiM maps to your EHR, your specialties, and your compliance posture — and what your first quarter could look like.